Mérieux Développement, the private equity arm of France-based biotechnology holding company Institut Mérieux, closed its second evergreen fund yesterday at €150m ($187m).
Sienna Capital, an affiliate of industrial holding company Groupe Bruxelles Lambert, has committed a total of $93.6m, which Institut Mérieux said would mostly be dedicated to the fund.
The cash will be spent on venture capital and growth equity investments in the healthcare sector. Mérieux Développement recently opened a US office in Cambridge, Massachusetts, signifying an increased focus…
